Skip to content
Biodatica
Start free

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

San Severo, Foggia

Filed/Approved
Sign in to watch

What changed

Filed/Approved trial registered: TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

Jun 2025Trial registeredJun 6, 2025Source filing (opens the source filing in a new tab)

Momentum

41no change

Momentum 41 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE4 registered

    Oct 31, 2018

    Myocardial Infarction · COMPLETED · sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III · TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"

    ClinicalTrials.gov · NCT03596385 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources